20.97
Upstream Bio Inc Borsa (UPB) Ultime notizie
Why retail investors pile into Upstream Bio Inc. stock2025 Major Catalysts & Reliable Price Action Trade Plans - Trung tâm Dự báo KTTV quốc gia
Will Upstream Bio Inc. stock outperform growth indexesSell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Upstream Bio Inc. stock trading at a premium valuationJuly 2025 PreEarnings & Real-Time Price Movement Reports - newser.com
Upstream Bio (NASDAQ:UPB) Earns Buy Rating from Analysts at Truist Financial - Defense World
Can Upstream Bio Inc. stock sustain revenue growthJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
Upstream Bio Presents New Structural Data on Verekitug, Highlights Unique TSLP Receptor Targeting - Insider Monkey
What earnings revisions data tells us about Upstream Bio Inc.Trade Exit Report & Verified Short-Term Trading Plans - newser.com
How resilient is Upstream Bio Inc. stock in market downturnsPortfolio Value Report & Safe Entry Trade Signal Reports - newser.com
Truist Securities Initiates Coverage on Upstream Bio (UPB) with a Buy Rating | UPB Stock News - GuruFocus
Truist Securities initiates Upstream Bio stock with Buy rating on respiratory drug potential - Investing.com
Upstream Bio initiated with a Buy at Truist - TipRanks
What to do if you’re stuck in Upstream Bio Inc.July 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
Why Upstream Bio (UPB) Is Up 6.5% After Positive Phase 2 Results for Verekitug in Respiratory Diseases - Sahm
Upstream Bio's (UPB) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Will Rising Interest Rates Hurt Vintage Coffee and Beverages Limiteds Profit MarginsMonthly Performance Summary & Free Stop-Loss Planning for Your Portfolio - earlytimes.in
Measuring Upstream Bio Inc.’s beta against major indicesJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
What does recent volatility data suggest for Upstream Bio Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
What drives Upstream Bio Inc stock priceVolume Weighted Average Price & Plan Your Future With Strategic Investing - earlytimes.in
Visualizing Upstream Bio Inc. stock with heatmapsJuly 2025 Rallies & Technical Analysis for Trade Confirmation - newser.com
Can volume confirm reversal in Upstream Bio Inc.Trade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Applying Elliott Wave Theory to Upstream Bio Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com
Upstream Bio (UPB): Assessing Valuation as Shares Climb 7% Over the Past Week - Yahoo
Assessing Upstream Bio (UPB) Valuation After New Verekitug Phase 2 Data and Investor Interest Surge - Sahm
Upstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Why Upstream Bio (UPB) Is Up 14.0% After Positive Phase 2 Verekitug Data and Novel Dosing Approach - Sahm
News impact scoring models applied to Upstream Bio Inc.2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Is Upstream Bio Inc. forming a reversal patternJuly 2025 Update & Community Supported Trade Ideas - newser.com
Is Upstream Bio Inc. stock attractive for passive investorsMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Earnings visualization tools for Upstream Bio Inc.July 2025 Earnings & Trade Opportunity Analysis - newser.com
Upstream Bio Inc Stock Analysis and ForecastPrice Channel Trading & Free Popular Stock Picks Selection - earlytimes.in
Is Upstream Bio Inc. building a consolidation baseTrade Analysis Summary & Scalable Portfolio Growth Ideas - newser.com
Upstream Bio (NASDAQ:UPB) Trading 4.2% HigherStill a Buy? - MarketBeat
Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress - The Manila Times
Upstream Bio Presents Data Showing Structural and - GlobeNewswire
24-Week TSLP Inhibition: Upstream Bio's Verekitug Shows Breakthrough Respiratory Disease Treatment Data - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):